Jan 12, 2019 - The Lakers squander an opportunity against a Jazz team playing without all three of its normal point guards and lose 113-95. Donovan Mitchell (33 points, nine assists) leads Utah, while L.A. shoots just 36 percent.
Jan 08, 2019 - The following slide deck was published by Jazz Pharmaceuticals, Inc. in conjunction with this event.
Jan 07, 2019 - Nektar's pain drug NKTR-181 is up for review in May. Upside is triple digits, downside about 60-70%.Merck's Keytruda is up for review in February for melanoma.Jazz JZP-110 for excessive sleepiness is
Jan 04, 2019 - Jazz (JAZZ) collaborates with Codiak for research, development and commercialization of exosome therapeutics to treat cancer.
Dec 28, 2018 - Management execution has been stellar in 2018; I expect 2019 will be similar.However, the share price has not moved in tandem. Major shareholders are going to hold management accountable for the share
Dec 24, 2018 - Jazz (JAZZ) announces that the FDA has extended the review period of its new drug application for sleep drug, solriamfetol, by three months to Mar 20, 2019.
Dec 11, 2018 - Jazz's (JAZZ) board sanctions a raise in its share buyback authorization by $400 million.
Dec 11, 2018 -
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech stocks hitting 52-week highs on Dec. 10)
Dec 06, 2018 - Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nov 29, 2018 - The first patient has been enrolled in a Phase 3 clinical trial evaluating Jazz Pharmaceuticals' (NASDAQ:JAZZ) JZP-258 in patients with idiopathic hypersomnia (excessive daytime sleepiness of unknown